We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mircera Gets FDA Approval But Will Not Be Launched

Law360 (November 15, 2007, 12:00 AM EST) -- Roche Holding AG said Thursday that the U.S. Food and Drug Administration had approved its anemia treatment Mircera but that it won't launch the drug until a patent dispute with Amgen...
To view the full article, register now.